Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01514409
Other study ID # 24AQ1
Secondary ID
Status Completed
Phase N/A
First received January 17, 2012
Last updated January 20, 2012
Start date May 2011
Est. completion date August 2011

Study information

Verified date January 2012
Source Northumbria University
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

5-hydroxytryptophan (5-HTP) is a nutritional supplement sold in many health food stores, and is taken in order to raise levels of serotonin in the brain. Serotonin is a neurotransmitter that is involved in the regulation of mood.

Previous research has assessed the effects of raising serotonin levels using tryptophan (the precursor of 5-HTP) and serotonergic antidepressants on emotional processing in healthy volunteers. However, to date there has been no human trial investigating the effects of 5-HTP on emotional processing in healthy volunteers.

Thus, the current study aims to assess the effects of 5-HTP, on emotional processing and mood in healthy volunteers.


Description:

The serotonin precursor 5-HTP is sold as a nutritional supplement and has been used to offset low mood for over 30 years due to its ability to raise levels of neural serotonin. However, evidence for the efficiency of 5-HTP is limited and the mechanism of action of 5-HTP in offsetting low mood has not been well-characterised.

The current study assessed the ability of 5-HTP to induce biases for positive emotional material in healthy volunteers, similar to those induced by serotonergic antidepressants and the nutritional supplement tryptophan. The effects of 5-HTP on subjective mood and depressive symptoms were also assessed.

Participants were randomised to receive either 150mg of 5-HTP or placebo daily for 14 days. Depressive symptoms and subjective mood were assessed pre- and post-intervention. Emotional processing was assessed on the 15th day using a battery of emotionally valenced cognitive tasks.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date August 2011
Est. primary completion date August 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Male/Female

- Healthy

- Aged 18-65

- Not taking any herbal or prescription medications (excluding contraceptive pill)

- Free from depressive illness or mood disorder for the last 6 months

- Free of physical illness

Exclusion Criteria:

- Physically ill

- History of medical illness

- Current or previous (6 month) history of psychiatric disorder

- Pregnant/breastfeeding

- Allergy or hypersensitivity to any of the ingredients contained in the investigational product

- Taking any medication (excluding contraceptive pill)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
5-Hydroxytryptophan
Thirty-three participants were randomly allocated in a double-blind manner to receive either 3x50mg capsules of 5-HTP or placebo (silica) for 14 days. 5-HTP is produced commercially by extraction from the seeds of the African plant griffonia simplicifolia.
Pharmaceutical grade silica
Pharmaceutical grade silica was utilized as placebo

Locations

Country Name City State
United Kingdom Northumbria University Newcastle Upon Tyne

Sponsors (1)

Lead Sponsor Collaborator
Northumbria University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Beck Depression Inventory-II (BDI-II) The BDI-II is a measure used to assess the severity of depressive symptoms. It is comprised of 21 items that are scored on a scale ranging from 0-3, with total scores ranging from 0-63. Scores of over 16 are indicative of depressive symptoms. 14 days No
Primary Profile of Mood States-Bipolar (POMS-BI) The POMS-BI is a measure used to assess subjective mood. It comprises 72 adjectives which describe mood states. Participants indicate how well the adjectives describe how they feel on a four point scale ranging from 0-3. The POMS-BI measures the following six bipolar mood states: composed-anxious, elated-depressed, agreeable-hostile, clearheaded-confused, energetic-tired, and confident-unsure. 14 days No
Primary Emotional Perception: Facial Expression Recognition Task Participants are shown faces displaying five different emotions - happiness, sadness, fear, anger, and disgust. Each facial expression has been morphed between 0% (neutral) to 100% in 25% increments. Four examples of each emotion at each intensity are displayed on a computer screen (84 stimuli presentations in total). Faces are displayed for 500ms aand then replaced with a blank screen. Participants have to indicate what facial expression has been displayed by clicking the corresponding button on-screen with the mouse. Accuracy, reaction times, and misclassifications are measured. 14 days No
Primary Emotional Categorisation and Memory Participants are shown sixty personality characteristics consecutively (30 agreeable, 30 disagreeable)on a computer screen in random order for 500ms each. Participants are asked to judge whether the personality traits are 'likeable' or 'dislikeable'. Classifications and reaction times for correct choices are recorded. Participants are then asked to recall as many personality characteristics as they can in order to assess their incidental memory for positive versus negative material. 14 days No
Primary Emotional Attention: Attentional Probe Task The attentional probe task based on MacLeod, Matthews and Tata's (1986) visual attention paradigm is used to assess participants attention towards positive versus negatively valenced words. Accuracy and reaction time is recorded. 14 days No
See also
  Status Clinical Trial Phase
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05516264 - Behavioural and Physiological Responses to Dog Visits in Nursing Homes N/A
Completed NCT05555186 - The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being N/A
Completed NCT04706806 - Effect of Daily Vinegar Ingestion for Four Weeks on Mood State in Healthy College Students N/A
Completed NCT04013451 - The Kiss of Kindness Study II N/A
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Completed NCT04440553 - A Mobile App to Increase Physical Activity in Students N/A
Completed NCT04505800 - Tryptophan Supplementation to Improve Night Shift Workers' Health N/A
Active, not recruiting NCT06082778 - ZOE's Ferment Experiment N/A
Completed NCT05100589 - Effect of PeakATP on Mood, Reaction Time and Cognition N/A
Completed NCT05559372 - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes N/A
Active, not recruiting NCT04641689 - Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment N/A
Active, not recruiting NCT01725425 - The Effect of Portion Sizes on Mood N/A
Completed NCT01794351 - Cognitive Effects of 500mg Trans-resveratrol N/A
Completed NCT05550610 - Evaluation of Mindfulness and Yoga in Basic Combat Training N/A
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A
Recruiting NCT05058872 - Contraceptive Hormone and Reward Measurement (CHARM Study) Phase 4
Not yet recruiting NCT04551274 - Music Therapy in Frontline Healthcare Workers N/A
Completed NCT03105973 - Technology Enabled Mental Health Intervention for Individuals in the Criminal Justice System N/A
Completed NCT04075448 - The Acute Effect of a Walnut Intervention on Cognitive Performance, Brain Activation, and Serum Markers of Inflammation in Young Adults N/A